×
About 1,488 results

ALLMedicine™ Calciphylaxis Center

Research & Reviews  709 results

Calciphylaxis in Stage 3 Chronic Kidney Disease on Apixaban Successfully Treated With S...
https://www.ncbi.nlm.nih.gov/pubmed/33166270
Wounds : a Compendium of Clinical Research and Practice; Ali F, Matharu T et. al.

Nov 9th, 2020 - Calciphylaxis is a serious condition that often occurs in patients with end-stage renal failure undergoing hemodialysis, with potential comorbidities of hyperparathyroidism and chronic kidney disease (CKD). It is a result of progressive calcificat...

Mimics of vasculitis.
https://doi.org/10.1093/rheumatology/keaa495
Rheumatology (Oxford, England); Maningding E, Kermani TA

Nov 9th, 2020 - While prompt diagnosis of vasculitis is important, recognition of vasculitis mimics is equally essential. As in the case of vasculitis, an approach to mimics based on the anatomic size of vessels can be useful. Infections can mimic vasculitis of a...

Assessment of outcomes of calciphylaxis.
https://doi.org/10.1016/j.jaad.2020.10.067
Journal of the American Academy of Dermatology; Gabel CK, Nguyen ED et. al.

Nov 1st, 2020 - Calciphylaxis is a rare thrombotic vasculopathy characterized by high morbidity and mortality. There is a paucity of studies examining longitudinal outcomes. To assess mortality, days spent in the hospital, and amputations in patients with calciph...

Gazing Into the Crystal Ball: Calciphylaxis Causing Striking Retinal Vascular Calcifica...
https://doi.org/10.1097/WNO.0000000000001090
Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society; Cherayil NR, Scoles D et. al.

Oct 26th, 2020 - A 72-year-old woman with membranous glomerulonephritis and failed renal transplant on peritoneal dialysis presented with bilateral vision loss. She reported several months of diminishing right eye vision that worsened after cataract extraction. On...

Fibroblast Growth Factor Receptor Inhibitors and Nonuremic Calciphylaxis.
https://doi.org/10.1001/jamadermatol.2020.4076
JAMA Dermatology; Hirner J, Cleary JM et. al.

Oct 14th, 2020 - Fibroblast Growth Factor Receptor Inhibitors and Nonuremic Calciphylaxis.|2020|Hirner J,Cleary JM,Sheets A,Murphy G,LeBoeuf N,|

see more →

Clinicaltrials.gov  733 results

Calciphylaxis in Stage 3 Chronic Kidney Disease on Apixaban Successfully Treated With S...
https://www.ncbi.nlm.nih.gov/pubmed/33166270
Wounds : a Compendium of Clinical Research and Practice; Ali F, Matharu T et. al.

Nov 9th, 2020 - Calciphylaxis is a serious condition that often occurs in patients with end-stage renal failure undergoing hemodialysis, with potential comorbidities of hyperparathyroidism and chronic kidney disease (CKD). It is a result of progressive calcificat...

Mimics of vasculitis.
https://doi.org/10.1093/rheumatology/keaa495
Rheumatology (Oxford, England); Maningding E, Kermani TA

Nov 9th, 2020 - While prompt diagnosis of vasculitis is important, recognition of vasculitis mimics is equally essential. As in the case of vasculitis, an approach to mimics based on the anatomic size of vessels can be useful. Infections can mimic vasculitis of a...

Assessment of outcomes of calciphylaxis.
https://doi.org/10.1016/j.jaad.2020.10.067
Journal of the American Academy of Dermatology; Gabel CK, Nguyen ED et. al.

Nov 1st, 2020 - Calciphylaxis is a rare thrombotic vasculopathy characterized by high morbidity and mortality. There is a paucity of studies examining longitudinal outcomes. To assess mortality, days spent in the hospital, and amputations in patients with calciph...

Gazing Into the Crystal Ball: Calciphylaxis Causing Striking Retinal Vascular Calcifica...
https://doi.org/10.1097/WNO.0000000000001090
Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society; Cherayil NR, Scoles D et. al.

Oct 26th, 2020 - A 72-year-old woman with membranous glomerulonephritis and failed renal transplant on peritoneal dialysis presented with bilateral vision loss. She reported several months of diminishing right eye vision that worsened after cataract extraction. On...

Fibroblast Growth Factor Receptor Inhibitors and Nonuremic Calciphylaxis.
https://doi.org/10.1001/jamadermatol.2020.4076
JAMA Dermatology; Hirner J, Cleary JM et. al.

Oct 14th, 2020 - Fibroblast Growth Factor Receptor Inhibitors and Nonuremic Calciphylaxis.|2020|Hirner J,Cleary JM,Sheets A,Murphy G,LeBoeuf N,|

see more →

News  39 results

An Unusual Presentation of Calciphylaxis
https://www.mdedge.com/dermatology/article/219998/rare-diseases/unusual-presentation-calciphylaxis/page/0/1?channel=44

Apr 1st, 2020 - The pathogenesis of calciphylaxis is not well understood; however, some researchers suggest that an imbalance in calcium-phosphate homeostasis may lead to calciphylaxis; that is, elevated calcium and phosphate levels exceed their solubility and de.

Nonuremic Calciphylaxis Triggered by Rapid Weight Loss and Hypotension
https://www.mdedge.com/dermatology/article/216159/mixed-topics/nonuremic-calciphylaxis-triggered-rapid-weight-loss-and/page/0/1?channel=45

Jan 27th, 2020 - Comment Background on Calciphylaxis Calciphylaxis is a rare but deadly disease that affects both ESRD patients receiving dialysis and patients without ESRD who have known risk factors for calciphylaxis, including female gender, white race, obesity.

Outpatient Management and Follow-up Recommendations for Adverse Drug Reactions: Guidelines for Posthospitalization Care
https://www.mdedge.com/dermatology/article/200161/mixed-topics/outpatient-management-and-follow-recommendations-adverse/page/0/1?channel=50892

May 3rd, 2019 - Long-term Sequelae Endocrine Thyroid gland abnormalities secondary to DRESS syndrome include Graves disease and Hashimoto disease as well as variations in biomarkers including elevated free thyroxine and low and elevated thyroid-stimulating hormon.

Update on Calciphylaxis Etiopathogenesis, Diagnosis, and Management
https://www.mdedge.com/dermatology/article/189412/wounds/update-calciphylaxis-etiopathogenesis-diagnosis-and-management/page/0/1

Nov 26th, 2018 - Prevention Reduction of the net calcium phosphorus product may help reduce the risk of calciphylaxis in ESRD patients, which can be accomplished by using non–calcium-phosphate binders, adequate dialysis, and restricting use of vitamin D and vitami.

see more →

Patient Education  7 results see all →